Schizophrenia

Recently Updated
Bill Gates - Makes Cannabis a Medicine Last Updated on 2017-09-20 13:55:09 Forbes  |  by Janet Burns For The Past 12 Years, Bill Gates Did What The FDA Won't: He Made Cannabis A Medicine In 2005, Bill Gates had a life changing meeting with veterans of the War in Afghanistan through the Bill & Melinda Gates Foundation. Ever since hearing their stories that day, Gates has set out to find the safest, most effective form of medicinal cannabis for treating the conditions of former solders and others, and to bring that product to the masses. After 12 years of non-stop research and advocacy, those goals are finally in hand..... Gates, whose company recovers CBD from cannabis plants using the 'green method' of supercritical fluid extraction (SFE) with C02 ... Cannabinoid, or CBD, is a miracle product that everyone has been using to Completete various conditions, including chronic pain, anxiety, nausea, rheumatoid arthritis,... More »
How CBD Changes The Brain To Treat Psychiatric Disorders Last Updated on 2017-07-25 11:56:36 Canna Tech |  July 25, 2017  |  By Jack Woodhouse In a recent study, published in Frontiers in Pharmacology, a group of scientists from the University of São Paulo in Brazil reviewed all the available research in order to learn more about the mechanisms at play when psychiatric disorders are treated with CBD. The study suggests that CBD’s therapeutic effects are caused by a number of acute mechanisms as well as changes in the structure of the brain over time, known as neuroplasticity. CBD has been proven to offer a broad spectrum of therapeutic actions, which include anxiolytic, antipsychotic, antidepressant, anticonvulsant, and neuroprotective effects. These have been studied over a large range of psychiatric and neurodegenerative disorders. Although most of these putative therapeutic properties were initially described in animal models, clinical... More »
A powerful new form of medical marijuana, without the high Last Updated on 2017-07-24 16:21:23 The Washington Post  |  December 31, 2016  |  By David Kohn ... in the past 10 years, scientists have concluded that CBD may be quite useful.  Dozens of studies have found evidence that the compound can treat epilepsy as well as a range of other illnesses, including anxiety, schizophrenia, heart disease and cancer ...   Source: https://www.washingtonpost.com/national/health-science/a-powerful-new-form-of-medical-marijuana-without-the-high/2016/12/29/81bbf7c0-b5b2-11e6-b8df-600bd9d38a02_story.html?utm_term=.3e5b037cbf41 More »
Could cannabidiol be used as an alternative to antipsychotics? Last Updated on 2017-07-18 18:23:58 Fakhoury M1.   Schizophrenia is a mental disorder that affects close to 1% of the population. Individuals with this disorder often present signs such as hallucination, anxiety, reduced attention, and social withdrawal. Although antipsychotic drugs remain the cornerstone of schizophrenia treatment, they are associated with severe side effects. Recently, the endocannabinoid system (ECS) has emerged as a potential therapeutic target for pharmacotherapy that is involved in a wide range of disorders, including schizophrenia. Since its discovery, a lot of effort has been devoted to the study of compounds that can modulate its activity for therapeutic purposes. Among them, cannabidiol (CBD), a non-psychoactive component of cannabis, shows great promise for the treatment of psychosis, and is associated with fewer extrapyramidal side effects than conventional antipsychotic drugs.... More »
Does cannabidiol have a role in the treatment of schizophrenia? Last Updated on 2017-07-18 18:20:39 Gururajan A1, Malone DT2.   Schizophrenia is a debilitating psychiatric disorder which places a significant emotional and economic strain on the individual and society-at-large. Unfortunately, currently available therapeutic strategies do not provide adequate relief and some patients are treatment-resistant. In this regard, cannabidiol (CBD), a non-psychoactive constituent of Cannabis sativa, has shown significant promise as a potential antipsychotic for the treatment of schizophrenia. However, there is still considerable uncertainty about the mechanism of action of CBD as well as the brain regions which are thought to mediate its putative antipsychotic effects. We argue that further research on CBD is required to fast-track its progress to the clinic and in doing so, we may generate novel insights into the neurobiology of schizophrenia. source:... More »